Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Should Cannabis Dosing Be Adjusted as Tolerance Develops in Sleep Apnoea? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Long-term use of cannabis for obstructive sleep apnoea (OSA)  may lead to tolerance, where the same dose becomes less effective over time. Understanding cannabis tolerance in sleep apnoea is key to maintaining therapeutic benefits without increasing risks. 

Am I eligible for medical cannabis for pain relief?

Managing Tolerance 

Developing cannabis tolerance in sleep apnoea is a common consideration for users who rely on cannabis nightly to reduce apnoea events. 

Dosage Adjustment 

Periodic dosage adjustment for OSA may be necessary to compensate for cannabis tolerance in sleep apnoea, ensuring continued efficacy in reducing airway collapse. 

Monitoring Effects 

Tracking sleep quality and daytime alertness helps identify when long-term cannabis use is leading to tolerance, guiding safe dosage adjustment for OSA. 

Rotational or Microdosing Strategies 

Implementing strategies such as microdosing or cycling between cannabis strains can help mitigate cannabis tolerance in sleep apnoea while preserving therapeutic benefit. 

Safety Considerations 

Increasing doses without monitoring can heighten the risks associated with long-term cannabis use, including sedation or dependency, making careful dosage adjustment for OSA essential. 

Awareness of cannabis tolerance in sleep apnoea and strategic dosage adjustment for OSA allow patients to maintain effective symptom control while minimising risks related to long-term cannabis use. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories